rBTI induces apoptosis in human solid tumor cell lines by loss in mitochondrial transmembrane potential and caspase
Yu-Ying Li1, Zheng Zhang, Zhuan-Hua Wang
1Key Laboratory for Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, 36 Wucheng Road, Taiyuan, 030006, China.
Abstract:
The molecular mechanisms and the possible effects of a recombinant buckwheat trypsin inhibitor (rBTI) on the induction of apoptosis in the human solid tumor cells (EC9706, HepG2 and HeLa) were investigated. An MTT assay showed that rBTI could specifically inhibit the growth of solid tumor cells in a dose- and time-dependent manner. Analysis by flow cytometry indicated that the apoptosis of several tumor cells increased after treatment with rBTI in range of 6.25-50microg/ml. DNA electrophoresis analysis showed the 'DNA ladder', typical of apoptosis. rBTI-induced apoptosis was shown to involve Bax and Bak up-regulation, Bcl-2 and Bcl-xl down-regulation, release of cytochrome c from the mitochondria to the cytosol, activation of caspase-3 and -9 and disruption of the mitochondrial transmembrane potential (Deltapsi(m)). The z-DEVD-fmk caspase-3 inhibitor significantly inhibited rBTI-induced apoptosis. We concluded that rBTI can induce the apoptosis in several types of human solid tumor cells and promotes apoptosis through the mitochondrial apoptotic pathway.
Insights
Recombinant buckwheat trypsin inhibitor (rBTI) effectively inhibits solid tumor cell growth and induces apoptosis. This occurs via the mitochondrial pathway, involving key proteins and caspase activation.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Solid tumors represent a significant global health challenge.
- Targeted therapies inducing apoptosis are crucial for cancer treatment.
- Understanding novel apoptosis inducers like recombinant buckwheat trypsin inhibitor (rBTI) is essential.
Purpose of the Study:
- To investigate the molecular mechanisms and effects of rBTI on human solid tumor cell apoptosis.
- To determine if rBTI can induce programmed cell death in cancer cells.
- To elucidate the specific apoptotic pathway activated by rBTI.
Main Methods:
- MTT assay for cell growth inhibition.
- Flow cytometry for apoptosis analysis.
- DNA electrophoresis for apoptosis detection.
- Mitochondrial pathway analysis (Bax, Bak, Bcl-2, Bcl-xl, cytochrome c, caspase-3, -9, Deltapsi(m)).
Main Results:
- rBTI specifically inhibited solid tumor cell growth dose- and time-dependently.
- rBTI treatment increased apoptosis in tumor cells (EC9706, HepG2, HeLa).
- Apoptosis involved mitochondrial pathway activation: Bax/Bak up-regulation, Bcl-2/Bcl-xl down-regulation, cytochrome c release, caspase-3/-9 activation, and mitochondrial potential disruption.
- Caspase-3 inhibition partially blocked rBTI-induced apoptosis.
Conclusions:
- rBTI induces apoptosis in human solid tumor cells.
- The mechanism involves the mitochondrial apoptotic pathway.
- rBTI shows potential as a therapeutic agent for solid tumors.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Caspases


